跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GPC3-CART
首页
药物
GPC3-CART
GPC3-CART
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of GPC3 and GPC3 CAR-T in diagnosis and treatment of idiopathic pulmonary fibrosis
CN 116555414 A
申请人: RUIJIN HOSPITAL SHANGHAI JIAOTONG UNIV SCHOOL MEDICINE
优先权: 2023
CN
2 件公开
Nucleic acid for treating HCC (Hepatocellular Carcinoma), preparation method thereof, CAR-T (Chimeric Antigen Receptor T) cell having nucleic acid and preparation method of CAR-T cell
CN 108913709 A
申请人: SHANDONG XINRUI BIOTECHNOLOGY CO LTD
优先权: 2018
CN
靶向GPC3和CD19双靶点的嵌合抗原受体方法和用途
CN 110724697 B
申请人: 上海恒润达生生物科技股份有限公司
优先权: 2018
CN
Method for constructing novel chimeric antigen receptor targeting dual target points of GPC3 and CD19
CN 111100205 A
申请人: SHANGHAI HRAIN BIOTECHNOLOGY CO LTD
优先权: 2018
CN
用于治疗HCC的核酸、其制备方法、具有该核酸的CAR-T细胞及细胞的制备方法
CN 112159818 B
申请人: 山东兴瑞生物科技有限公司
优先权: 2020
CN
GPC3-targeting fourth-generation CART cell with high expression of CCL-19 and preparation method and application of GPC3-targeting fourth-generation CART cell
CN 116769720 A
申请人: ZHONGSHAN HOSPITAL FUDAN UNIV
优先权: 2023
CN
Anti-GPC3 chimeric antigen receptor T cell of overexpression integrin beta3 and application of anti-GPC3 chimeric antigen receptor T cell
CN 120818538 A
申请人: FIRST AFFILIATED HOSPITAL MEDICAL COLLEGE XIAN JIAOTONG UNIV
优先权: 2025
CN
药物
反馈